SSY GROUP (02005): Acetylaminophenol tablets approved by the National Medical Products Administration for new 0.5g specification.
Sinopharm Group (02005) announced that the group's paracetamol tablets have been approved by the China National Medical Products Administration...
SSY GROUP (02005) announced that the group's paracetamol tablets have been approved by the National Medical Products Administration of China (NMPA) for a new 0.5g specification, and both the 0.3g and 0.5g paracetamol tablets have been approved by the NMPA for generic drug quality and therapeutic efficacy consistency evaluation.
Paracetamol tablets are mainly used for fever caused by common cold or influenza, and also used to relieve mild to moderate pain.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025